Skip to content

Clinical trials

Phase 2 Head and Neck Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20083
20091
20102
20111
20121
20141
20154
20173
20191
20201
20212
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting6
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital5
Yonsei University4
ALX Oncology Inc.2
AstraZeneca2
Kura Oncology, Inc.2
Pfizer2
Samsung Medical Center2
BeiGene1
Chonnam National University Hospital1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms27
Squamous Cell Carcinoma of Head and Neck14
Breast Neoplasms4
Ovarian Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Squamous Cell3
Pancreatic Neoplasms3
Recurrence3
Cholangiocarcinoma2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.